(Q47799102)

5 February 2018

title

Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus (English)

1 reference

5 February 2018

0 references

0 references

Juan F Navarro

1

1 reference

5 February 2018

Carmen Mora

series ordinal

2

1 reference

5 February 2018

Manuel Maca

series ordinal

3

1 reference

5 February 2018

Javier Garca

series ordinal

4

1 reference

5 February 2018

publication date

1 July 2003

1 reference

5 February 2018

American Journal of Kidney Diseases

published in

1 reference

5 February 2018

volume

42

1 reference

5 February 2018

issue

1

1 reference

5 February 2018

page(s)

53-61

1 reference

5 February 2018

End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

Pathogenesis, prevention, and treatment of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

Association between C-reactive protein and features of the metabolic syndrome: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

American Diabetes Association Annual Meeting, 1999: more on cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

New insights into the pathophysiology of diabetic retinopathy: potential cell-specific therapeutic targets

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

Transcapillary escape rate and albuminuria in Type II diabetes. Effects of short-term treatment with low-molecular weight heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

Protein C activation in NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

Lack of an association of urinary albumin excretion with interleukin-6 or C-reactive protein in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

Effect of losartan on plasma C-reactive protein in type 2 diabetic patients with microabluminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

Optimal dose of losartan for renoprotection in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

mRNA expression of growth factors in glomeruli from diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

RAGE: a novel cellular receptor for advanced glycation end products

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

Receptor-mediated interactions of advanced glycosylation end products with cellular components within diabetic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

Cytokine actions of angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

Proinflammatory actions of angiotensins.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900408-6

7 January 2021

10.1016/S0272-6386(03)00408-6

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

12830456

1 reference

5 February 2018